Baker Brothers Advisors - ALDER BIOPHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of ALDER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q2 2017$2,488,000
-45.0%
217,3280.0%0.02%
-40.5%
Q1 2017$4,520,0000.0%217,3280.0%0.04%
-15.9%
Q4 2016$4,520,000
-36.5%
217,3280.0%0.04%
-32.3%
Q3 2016$7,122,000
+31.2%
217,3280.0%0.06%
+14.0%
Q2 2016$5,427,000
-67.7%
217,328
-57.7%
0.06%
-63.2%
Q3 2015$16,820,000
-64.4%
513,439
-42.4%
0.16%
-62.6%
Q2 2015$47,233,000
+86.1%
891,688
+1.4%
0.41%
+96.2%
Q1 2015$25,385,000
+469.0%
879,581
+473.6%
0.21%
+358.7%
Q4 2014$4,461,000
+129.5%
153,3500.0%0.05%
+91.7%
Q3 2014$1,944,000
-36.8%
153,3500.0%0.02%
-36.8%
Q2 2014$3,078,000153,3500.04%
Other shareholders

There were no reported owners of ALDER BIOPHARMACEUTICALS INC in Q3 2023.

NameSharesValueWeighting ↓
View complete list of ALDER BIOPHARMACEUTICALS INC shareholders